ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2019

Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor.

Hitoshi Ishii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.